Leerink Partners Maintains Quanterix(QTRX.US) With Buy Rating
Leerink Partners Sticks to Its Buy Rating for Quanterix (QTRX)
Analysts Offer Insights on Healthcare Companies: Quanterix (QTRX), Doximity (DOCS) and Warby Parker (WRBY)
Quanterix Price Target Cut to $28.00/Share From $32.00 by Scotiabank
Scotiabank Keeps Their Buy Rating on Quanterix (QTRX)
Quanterix Analyst Ratings
Hold Rating on Quanterix Amid Modest Sales Performance and Market Uncertainty
Analysts' Top Healthcare Picks: Trevi Therapeutics (TRVI), Quanterix (QTRX)
Scotiabank Maintains Quanterix(QTRX.US) With Buy Rating, Maintains Target Price $32
Quanterix Analyst Ratings
Outperform Rating and $30 Price Target for Quanterix Amid Strong Position in Alzheimer's Diagnostics Market
Scotiabank Reaffirms Their Buy Rating on Quanterix (QTRX)
Buy Rating on Quanterix: Strong Performance and Growth Potential Amid Competitive Market
Quanterix Analyst Ratings
Analysts' Top Healthcare Picks: Quanterix (QTRX), Intuitive Surgical (ISRG)
Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX) and Quanterix (QTRX)
Quanterix's Strong IP Position Fuels Buy Rating in Alzheimer's Diagnostic Market
Analysts Are Bullish on Top Healthcare Stocks: Quanterix (QTRX), Passage Bio (PASG)
Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI), Oculis Holding (OCS) and Quanterix (QTRX)
TD Cowen Sticks to Their Hold Rating for Quanterix (QTRX)